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Alveolar type II pneumocytes (ATII) and alveolar macrophages (AM) play a crucial role
in the lung’s innate immune response. Burkholderia pseudomallei (BP ) and Burkholderia
mallei (BM) are facultative Gram-negative bacilli that cause melioidosis and glanders,
respectively. The inhalation of these pathogens can cause lethal disease and death in
humans. We sought to compare the pathogenesis of and host responses to BP and
BM through contact with human primary ATII cells and monocytes-derived macrophages
(MDM). We hypothesized that because BP and BM induce different disease outcomes,
each pathogen would induce distinct, unique host immune responses from resident
pulmonary cells. Our findings showed that BP adhered readily to ATII cells compared
to BM. BP, but not BM, was rapidly internalized by macrophages where it replicated to
high numbers. Further, BP -induced significantly higher levels of pro-inflammatory cytokine
secretion from ATII cells (IL-6, IL-8) and macrophages (IL-6, TNFα) at 6 h post-infection
compared to BM (p < 0.05). Interestingly, BM-induced the anti-inflammatory cytokine,
IL-10, in ATII cells and macrophages at 6 h post-infection, with delayed induction of
inflammatory cytokines at 24 h post-infection. Because BP is flagellated and produces
LPS, we confirmed that it stimulated both Toll-like receptor (TLR) 4 and TLR5 via NF-κb
activation while the non-flagellated BM stimulated only TLR4. These data show the
differences in BP and BM pathogenicity in the lung when infecting human ATII cells
and macrophages and demonstrate the ability of these pathogens to elicit distinct
immune responses from resident lung cells which may open new targets for therapeutic
intervention to fight against these pathogens.
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INTRODUCTION
Burkholderia pseudomallei (BP) and Burkholderia mallei (BM) are
facultative-intracellular Gram-negative bacilli that cause melioi-
dosis and glanders, respectively (White, 2003; Gilad, 2007; Galyov
et al., 2010). BP is a highly motile pathogen (Dance, 1991;
Leelarasamee, 2004; Lazar Adler et al., 2009; Wikraiphat et al.,
2009) that causes melioidosis in animals and humans (White,
2003; Gilad, 2007). The clinical symptoms of BP are difficult to
diagnose because they present as flu-like symptoms, pneumonia,
or septicemia (Dance, 1991; Leelarasamee, 2004; De Keulenaer
and Cheng, 2006; Cheng et al., 2007). Melioidosis is endemic in
subtropical and tropical areas, with most cases found in Southeast
Asia and northern Australia where it is the most common cause
of community-acquired pneumonia (White, 2003; Gilad, 2007;
Galyov et al., 2010). A pulmonary BP infection can disseminate
to distal organs with consequential development of bacteremia
that can lead to death (White, 2003; Lazar Adler et al., 2009). In
contrast, the closely related BM is a non- motile pathogen that
is the etiological agent of glanders that persists in its equine host
to survive (Redfearn et al., 1966; Gilad, 2007; Galyov et al., 2010).
If transmitted to humans, the clinical signs of the disease are
febrile pneumonia accompanied resulting in dissemination from
the lungs to distal organs causing bacteremia and necrosis
(Redfearn et al., 1966; Gilad, 2007; Galyov et al., 2010). Therefore,
both of these pathogens are considered viable candidates for use
as bioweapon agents via aerosolization effecting a large populated
area.
BP and BM are phylogenetically very similar containing nearly
identical 16S ribosomal DNA sequences with genome variations
between the strains (Godoy et al., 2003; Holden et al., 2004).
The BP genome contains two chromosomes, a large chromo-
some of 4.07Mb that carries genes associated for metabolism and
growth, and a smaller chromosome (3.17Mb) encoding genes
responsible for environmental adaptation and bacterial survival
including the type III secretion system, capsule, and flagellum
(Holden et al., 2004). BM also has two chromosomes but has a
downsized genome. Chromosome 1 (3.5Mb) encodes for genes
involved in exopolysaccharide capsule, LPS, type IV pili, and type
III and IV secretion systems (Holden et al., 2004) while chro-
mosome 2 (2.3Mb) carries genes encoding for LPS biosynthesis,
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capsule production and bacterial metabolism (Holden et al.,
2004). Unlike BP, BM is non-flagellated and non-motile due to IS
elements that disrupts the fliP gene, an essential gene for flagel-
lum biogenesis, and a frameshift mutation in the flagellummotor
gene that eliminates its function (Holden et al., 2004).
Although both pathogens share some antigenicity and
virulence-associated similarities their disease outcomes are quite
unique. While both BP and BM have been shown to readily
adhere and invade transformed human and murine macrophage-
like cell lines (Jones et al., 1996; Stevens and Galyov, 2004;
Pudla et al., 2011) and ATII cell lines (Kespichayawattana et al.,
2004; Utaisincharoen et al., 2004, 2005; Boddey et al., 2006; Sim
et al., 2009; Whitlock et al., 2009; Balder et al., 2010), rela-
tively few studies have examined the immunological outcomes-
induced following infection of primary human cells (Nathan
and Puthucheary, 2005; Puthucheary and Nathan, 2006) or per-
formed direct comparisons of their differential infectivity process.
This is likely due to the level 3 bio-containment facilities necessary
to perform experiments with BM and BP. With the atmosphere
of uncertainty following the tragic events of September 11th,
2001 the potential for these highly pathogenic organisms to be
used as a biological weapon via aerosolization is a real possi-
bility. Therefore, to gain a better understanding of BM and BP
pathogenesis in the lung, we examined the induction of innate
immune responses by primary human pulmonary cells in the
early stages of BM or BP infection. The lung is constantly exposed
to harmful inhaled environmental factors (i.e., bacteria, viruses,
and chemicals). Pulmonary defenses have evolved such that the
physiological positioning of resident alveolar cells are able to
clear and/or fight against harmful particles. For example, alveolar
macrophages (AM) are considered the first line of defense against
inhaled pathogens. Successful pathogenic bacteria have devel-
oped mechanisms to subvert host defenses. Murine studies with
BP showed macrophage invasion without activation of inducible
nitric oxide synthase responsible for production of nitric oxide
crucial to host attacks on intracellular bacteria (Utaisincharoen
et al., 2001). The studies reported by Puthucheary and colleagues
(Nathan and Puthucheary, 2005; Puthucheary and Nathan, 2006)
indicated that BP was able to survive and replicate more suc-
cessfully in macrophages collected from patients with melioidosis
than normal macrophages from healthy volunteers. Additionally,
Brett et al. (Balder et al., 2010) reported that BM LPS was a
potent stimulator of cytokine secretion from human monocyte-
derived macrophages (MDM) via TLR4, however, these studies
did not examine the intact live pathogen. The interaction of BM
with primary human macrophages is less studied and poorly
understood.
Another residential pulmonary cell that will inevitably come
into contact with inhaled Burkholderia is ATII cells, that repre-
sent approximately 4–5% of the cells in the alveolar space but
comprises 15% of all the cells in the lung (Crapo et al., 1982,
2000; Novick et al., 1996; Mason, 2006). These non-professional
immune cells are absolutely necessary formaintaining pulmonary
homeostasis, specifically via the secretion of surfactants (Novick
et al., 1996; Wright, 2005; Mason, 2006; Halliday, 2008; Pudla
et al., 2011). ATII cells also are crucial, unconventional con-
tributors to innate immunity via cytokine secretion, specifically
chemokines and signaling molecules for professional immune
cells including AM (O’Brien et al., 1999; Pechkovsky et al.,
2000, 2005; Gentry et al., 2007). We have shown that the lethal
pathogen, Francisella tularensis, stimulated polarized, primary
human ATII cells to secrete chemotactic mediators that induced
immune migration (Gentry et al., 2007). While there are vari-
ous publications that describe BM (Whitlock et al., 2009) and
BP (Stevens and Galyov, 2004; Utaisincharoen et al., 2005; West
et al., 2008) interactions with non-polarized, transformed human
A549 ATII cells, there are no reports using human primary ATII
cells. Thus to remain physiologically, we utilized our ex vivo pri-
mary human ATII cell model as well as human MDM in the
current studies to examine the pathogenic differences between
BM and BP as revealed through their interactions with these
residential pulmonary cells to induce different innate immune
responses. These studies revealed that in the early stages of
infection, BP, but not BM, readily adhered to ATII cells and
macrophages and stimulated both TLR4 and TLR5 via its LPS
and flagellin respectively. BP also induced high levels of cytokine
secretion from ATII cells andMDM in the first 6 h after infection.
Conversely, upon initial infection, BM-induced an inflamma-
tory suppressor, IL-10, from ATII cells and macrophages with
delayed secretion of inflammatory cytokines via TLR4 at 20 h
post-infection.
MATERIALS ANDMETHODS
BACTERIAL STRAINS
Burkholderia mallei (BM) China 7 (3873, MM-B, NBL7) and
Burkholderia pseudomallei (BP) China 3 (MP-H, NBL 104)
were obtained from BEI Resources (Manassas, VA) and prop-
agated overnight at 37◦C in Luria-Bertani (LB) broth (Difco
Laboratories, Detroit, MI) from frozen stocks. Bacterial titers
were determined using a Bel-Art—KLETT™ Colorimeter (Bel-
Art Products, Pequannock, NJ) and confirmed by plating serial
dilutions on LB agar plates. Both BM and BP are CDC classified
category A select agent thus they were used in UTMB’s certified
BSL3 facility as per CDC and Federal regulations.
HUMAN CELL CULTURES
Primary human type II alveolar epithelial (ATII) cells (ScienCell,
San Diego, CA) were seeded on BioCoat Growth Factor Reduced
Matrigel®-coated transwell filters (BD; Franklin Lakes, NJ) and
maintained using Bronchial Epithelial Medium enhanced with
the Bullet kit supplements provided by the manufacturer (BEGM;
Lonza, Basel, Switzerland) supplemented with 10% charcoal-
stripped FBS (Hyclone; Logan, UT) and 10 ng/mL of keratinocyte
growth factor (KGF; PeproTech, Rockhill, UT). ATII cells were
grown to confluence (4–5 days) then used for experiments. Before
each experiment, the A549 or ATII cells were washed 2X with
appropriate medium containing no serum or antibiotics. The
serum-free medium used during experimentation ensured no
interference by serum proteins and did not adversely affect the
health or metabolic activity of the cells.
Human monocytes were isolated from peripheral blood
mononuclear cells obtained from healthy donors with full
approval of the UTMB IRB. Monocytes were isolated using a
Hypaque-Ficoll (GE Healthcare, Piscataway, NJ) density gradient
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(800× g at 21◦C) followed by selection using a human mono-
cyte enrichment kit without cd16 depletion (Stemcell #19058)
and Easysep magnet (Stemcell #18000) counterflow centrifugal
elutriation (Beckman J2-21 M/E centrifuge with JE-B6 elutriator
rotor, Beckman Instruments, Palo Alto, CA). The purified mono-
cytes were cultured in RPMI 1640, 10% FBS supplemented with
GM-CSF (100 ng/mL) for 7 days to ensure differentiation into
macrophages as previously described (Eaves-Pyles et al., 2011).
The macrophages were detached from the culture plate using a
non-enzymatic cell dissociation solution (Sigma-Aldrich). MDM
differentiation was confirmed by flow cytometry of cell surface
markers expression (CD11b, CD80).
INFECTION MODEL AND CYTOKINE ANALYSES
ATII cells or MDM (5 × 105/condition) were infected with BM
or BP at an MOI of 100:1. Un-stimulated cells were used as nega-
tive controls. At 6 h post-infection, supernatants were collected
from ATII cells and MDM then frozen at −80◦C until analy-
sis. At the same time point, parallel ATII cells or MDM cultures
were washed with 2mL of PBS then incubated for 30min with
serum-free medium containing 50 ug/mL of gentamicin (Sigma).
ATII cells and MDM were washed then resuspended in serum-
free medium containing 5 ug/mL of gentamicin and incubated
an additional 14 h at 37◦C/5% CO2. Supernatants were collected
at 20 h post-infection then 6 and 20 h supernatants were ana-
lyzed via individual human ELISA kits (Pierce-Endogen) for the
following cytokines: IL-6, IL-8, IL-10, and/or TNF-α.
SCANNING ELECTRONMICROSCOPY (SEM)
ATII cells grown on transwell filters were exposed apically to
BM or BP at an MOI of 100:1 for 4 h. Then filters were fixed
in a mixture of 2.5% formaldehyde, 0.1% glutaraldehyde in
0.05M cacodylate buffer pH 7.2 containing 0.03% trinitrophe-
nol and 0.03% CaCl2, washed in 0.1M cacodylate buffer pH
7.2 and post-fixed in 1% OsO4 in the same buffer. The filters
were then dehydrated in ethanol and incubated with hexam-
ethyldisalazane. After the filters were air-dried they were sput-
ter coated for 40 s with iridium in an Emitech K575X turbo
sputter coater (Emitech, Houston, TX). Samples were visualized
using a Hitachi S4700 field emission scanning electron micro-
scope (Hitachi High Technologies America, Electron Microscope
Division, Pleasanton, CA) at 2 kV (UTMB Electron Microscopy
Laboratory Facility).
BACTERIAL ADHESION AND INVASION ASSAYS
The ability of BM and BP to adhere to ATII cells was performed
as previously described (Eaves-Pyles et al., 2008). Briefly, the cells
were grown on 24-well plates to confluence at 37◦C in 5% CO2
then infected with BM or BP at an MOI of 100:1 for 4 h at 37◦C.
To quantify adherence of the pathogens, the infected cells were
washed twice with PBS then lysed with 200μl of 0.1% Triton
X-100 in PBS buffer. The adherent bacteria were plated, incu-
bated and then colonies were counted the following day. To obtain
accurate counts of the pathogen that adhered to ATII cells, bac-
terial invasion experiments were performed in parallel to the
bacterial adhesion. Then the number of bacteria that invaded the
cells was subtracted from the number of bacteria that adhered to
the cells. Therefore, pathogen invasion was determined by infect-
ing ATII cells with BM or BP as described above. Four hours
post-infection, cells were washed twice with sterile PBS and then
incubated with DMEM containing 50 ug/mL gentamicin for 1 h
to kill extracellular bacteria. Cells were washed with PBS, lysed
with 0.1% Triton X-100, plated and colonies were counted the
following day as above.
MACROPHAGE PHAGOCYTOSIS AND INTRACELLULAR REPLICATION
OF BM AND BP
MDM (5 × 105 cells) were stimulated with BP or BM (MOI
100:1). To examine phagocytosis and intracellular replication of
BM and BP, at 1 h post-infection, macrophages were washed
with 2mL of PBS then incubated for 30min with serum-free
medium containing 50 ug/mL of gentamicin (Sigma) to kill extra-
cellular bacteria (Eaves-Pyles et al., 2001a). Cells were lysed by
adding 0.1% SDS and lysates were plated on BHI plates and
incubated at 37◦C in 5% CO2 overnight to allow quantifica-
tion of bacterial phagocytosis. To quantify intracellular replica-
tion of the pathogens, parallel macrophage cultures were treated
and infected as described above. However, following the 30min
gentamicin incubation, cells were washed then resuspended in
serum-free medium containing 5 ug/mL of gentamicin. Cells were
incubated an additional 3 h at 37◦C/5% CO2 then lysed, plated,
and single colonies were counted as described above.
TLR STIMULATION BY BM OR BP
As described previously (Gentry et al., 2007), human embry-
onic kidney (HEK) 293 cells genetically manipulated to express
human TLR4, or TLR5 (Invivogen, San Diego, CA) were cultured
and maintained in DMEM (Cellgro Mediatech) supplemented
with 10% FBS, 100 units/mL pencillin, 100 ug/mL streptomycin,
10 ug/mL basticidin, and 2mM glutamine. To analyze activa-
tion of the transcription factor NF-κb, each of HEK293 cell lines
were transfected with the pNF-κB-secreted alkaline phosphatase
(pNF-κB-SEAP) reporter plasmid (Clontech, Mountain View,
CA) using Lipofectamine Plus 188 (Invitrogen) per the manu-
facturer’s instructions. The day after transfection, the existing
medium was replaced with fresh DMEM containing no antibi-
otics followed by the addition of BM or BP at an MOI of
100:1. Commercial TLR agonists (Invivogen) were used as pos-
itive controls that included LPS (TLR4) and flagellin (TLR5).
Medium alone and HEK293 cells with no agonist served as neg-
ative controls. The cells were incubated for 6 h then medium was
aspirated and replaced with fresh DMEM with antibiotics and
incubated overnight at 37◦C and 5%CO2. Collected Supernatants
were heat inactivated for 30min at 65◦C. SEAP activity in each
sample was quantified (Mason, 2006) by the Phospha-Light
Chemiluminescence Reporter Assay (Tropix, Bedford, MA) and
a TR717 microplate 195 luminometer with WinGlow software
(Tropix/PE Applied Biosystems, Bedford, MA196).
WESTERN IMMUNOBLOT
Western blots were performed as we described previously (Eaves-
Pyles et al., 2001a,b). Briefly, supernatants from BM and BP (as
collected above) were analyzed for the amount of protein in each
sample by the Bradford assay (Bio-Rad, Hercules, CA). The super-
natants were boiled in loading buffer [4% SDS, 20% glycerol,
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125mM Tris-HCl (pH 6.8), and 10% 2-mercaptoethanol] then
40μg of protein was loaded on an 8–16% Tris-glycine gradi-
ent gel (Novex, San Diego, CA). Electrophoresed proteins were
transferred to a nitrocellulose membrane (Novex) and mem-
branes were blocked with 10% nonfat dried milk for 30min
prior to incubation with rabbit polyclonal anti-(FliC) flagellin
(BioLegend, San Diego, CA) at a dilution of 1:1000 overnight.
Blots were washed, followed by the addition of peroxidase-
conjugated anti-rabbit immunoglobulin G (Sigma Chemical Co.,
St. Louis, MO) at a dilution of 1:10,000 for 3 h. Blots were washed
and then incubated for 1min in enhanced chemiluminescence
reagents (ECL kit; Amersham, Little Chalfont, Buckinghamshire,
England). Processed blots were placed on X-ray film (Kodak®) for
empirically optimized exposures.
STATISTICAL ANALYSIS
Numerical results are presented herein as mean ± SEM of two
or three-independent experiments containing replicate experi-
mental conditions per each experiment. Statistically analysis of
numerical data was completed by Student’s t-test or analysis of
variance (ANOVA) using Prism software (Graph Pad v4.0, San
Diego, CA). Differences were noted to be statistically significant
when the p value was< 0.05.
RESULTS
BP AND BM INTERACTWITH THE APICAL SURFACE OF ATII
We sought to visualize the interaction between BM or BP and
ATII cells during early stages of a pulmonary infection. To remain
biologically and physiologically relevant, ATII cells were grown
on transwell filters to allow polarization before being infected
apically with BM or BP. Four hours post-infection, scanning
electron microscopy (SEM) was used to visualize interactions
between the bacteria and the ATII cells. Figure 1 illustrates the
distinct differences between BM and BP’s contact with the ATII
cells. BM contacted the apical surface of ATII cells but did not
appear to readily adhere to the ATII cells at 4 h post-infection
as such the pathogen could be seen floating free in the medium
(Figures 1A,B). Conversely, BP consistently established intimate
contact with the apical surface of ATII cells (Figures 1C–E) where
ATII microvilli are wrapped around individual BP organisms
FIGURE 1 | B. mallei (BM) and B. pseudomallei (BP) interaction with
primary human ATII cells (ATII cells). ATII cells were grown on 3.0-um
transwell filters to confluence prior to apical exposure of BM and BP at an
MOI of approximately 100:1 for 4 h. Minimal contact of BM (A and B) with
ATII cells was visualized via SEM. However, BP (C–E) adhesion to the apical
surface of ATII cells was observed and the pathogen was entangled by the
ATII microvilli [D (white boxed area) and E]. Further, quantitative analysis of
attachment showed that BP significantly adhered better to ATII cells
compared to BM (p < 0.05; F). Data is representative of triplicate samples of
three experiments and is represented as mean ± SEM. ∗p < 0.05.
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(Figures 1D,E). In addition to these findings, quantitative anal-
ysis of pathogen adhesion to ATII cells showed that at 4 h
post-infection BP adhered to the apical surface of ATII cells
significantly better than BM (p < 0.05; Figure 1F). These data
demonstrate distinct differences between BM and BP as the effi-
cient adherence of BP to ATII cells is more pronounced in the
early stages of infection than BM’s ability to bind to host cells.
BM AND BP-INDUCED DISTINCT AS WELL AS TIME-DEPENDENT
CYTOKINE SECRETION FROM ATII CELLS ANDMDM
Both ATII cells and AM will be contacted by inhaled BM and BP
over the course of pulmonary infections. As such, we sought to
evaluate the responses of these residential professional immune
cells and epithelial cells responded to the pathogens in differ-
ent the stages of infection. MDM and ATII cells were infected
with BM or BP at an MOI of 100:1 then cells supernatants were
collected at 6 and 20 h post-infection. Results showed that BP
stimulated significantly higher levels of cytokine secretion from
MDM [Figures 2A (IL-6), B (TNFα)] and ATII cells [Figures 2D
(IL-6) and E (IL-8)] at both tested time points compared to
BM or uninfected controls (p < 0.05). At the later time point
it was observed that BM provoked responses. Specifically, secre-
tion of IL-6 and TNF-α from MDM and IL-6 and IL-8 from
ATII cells increased at 20 h post-infection (Figures 2A,B,D,E).
Interestingly, the anti-inflammatory cytokine, IL-10 was secreted
by ATII cells and MDM to significantly higher levels at 6 h post-
BM infection compared to BP, then IL-10 levels decreased by 20 h
post-infection, but remained higher than uninfected controls and
BP-infected cells (p < 0.05; Figures 2C,F).
These data demonstrate that BP and BM induce distinct
cytokines that benefits their specific survival in ATII cells and
macrophages. In the initial stages of infection, BP-induced vig-
orous immune responses in both cell types, while BM-induced
an anti-inflammatory response (i.e., IL-10) in the early stages of
infection then transitioned into a traditional immune response.
PHAGOCYTOSIS AND INTRACELLULAR REPLICATION OF BM AND BP
Because BM and BP interacted with MDM and ATII cells to
induce cytokines, we sought to determine the invasion capabil-
ities and intracellular replication of BM and BP in these host
cells. To this end, MDM and ATII cells were infected with BM
or BP (MOI 100:1) for 1 h to determine phagocytosis of the
pathogens and at 3 h post-infection to assess intracellular replica-
tion. Cells were lysed at each time point, plated then the bacterial
CFU were quantified. Several observations were made from these
data results. First, BP was more readily phagocytosed at 1 h
post-infection by hMDM (Figure 3A) compared to phATII cells
(p < 0.05; Figure 3B). However, BP replicated in both cell types
to relatively high numbers at 3 h post-infection (Figures 3A,B).
Second, the phagocytosis of BM by hMDM and ATII cells was
minimal (Figures 3A,B) but the intracellular replication of BM
in hMDM, but not in phATII cells, was considerably high at 3 h
post-infection (Figure 3A).
The culmination of these data showed that the professional
immune cell, macrophages, markedly surpassed the resident pul-
monary epithelial cells, ATII cells, in phagocytosing BP and
to a lesser extent BM. Both pathogens replicated rapidly to
high numbers in macrophages suggesting bacterial manipulation
and/or evasion of innate defenses.
STIMULATION OF TLRs BY BM AND BP
Because TLRs are at the forefront of recognizing invading
pathogens resulting in the up-regulation of innate immune
response via the NF-κb signal transduction pathway (Hatada
et al., 2000; O’Neill and Bowie, 2007), we investigated the abil-
ity of BP and BM to stimulate TLR4 and TLR5. We chose
TLR4 because it is the receptor for LPS and both pathogens are
Gram-negative microbes. Additionally, because BP, but not BM,
is flagellated, we hypothesized that BP flagellin would stimu-
late TLR5. Stability transfected HEK293 cells expressing human
TLR4 or TLR5were co-transfected with the NF-κb-SEAP reporter
plasmid then infected with BP or BM at an MOI of 100:1.
Following an overnight incubation, supernatants were collected
and analyzed for SEAP secretion. Un-stimulated cells were used
as negative controls while additional cultures of HEK293 TLR4
and TLR5 expressing cells were stimulated with their respec-
tive TLR agonist (purified LPS for TLR4 or flagellin for TLR5),
which served as positive controls. Our results showed that both
BP and BM-induced NF-κb activation via TLR4 stimulation that
was equivalent to purified LPS and significantly higher than flag-
ellin or un-stimulated controls (p < 0.05; Figure 4A). However,
as predicted, only the flagellated BP-induced NF-κb via TLR5
stimulation compared to BM and LPS (p < 0.05; Figure 4B). To
confirm the release of BP flagellin into the surrounding environ-
ment, immunoblot analysis detected the presence of flagellin in
the BP supernatant compared to no detection of flagellin in the
supernatant of BM (Figure 4C).
These findings demonstrate that BP, but not BM, possesses
various virulence factors that readily stimulate multiple TLRs
thereby rapidly inducing innate immune responses.
DISCUSSION
The importance of studying the pathogenesis of inhaled BM and
BP has become more imminent as their potential for agents of
bioterrorism has become known. Although BM and BP are in
the same genus of bacteria, in this current study our findings
showed that they demonstrate distinct pathogenicity character-
istics upon the infection of resident lung cells, providing better
understanding of their different disease outcomes.
Pathogen adhesion to host epithelial cells offers an opportu-
nity for invasion and ultimately colonization of the host. It has
been shown that both BM and BP possess certain genes that
aid in host cell adherences such as boaA adhesion genes while
others are exclusive to BP such as type IV pili, type III secre-
tion system, flagella (Inglis et al., 2003; Kespichayawattana et al.,
2004; Boddey et al., 2006; Balder et al., 2010). Flagella are rec-
ognized as important indirect contributors to bacterial virulence
as the motility provided by the flagellum structure is frequently
associated with the ability of a pathogen to move through its sur-
rounding environment, as well as aid in attachment, adhesion,
and invasion to host cells subsequently contributing to disease
processes (Komoriya et al., 1999; Eaves-Pyles et al., 2001a; Chua
et al., 2003; Ramos et al., 2004; Chuaygud et al., 2008). Our find-
ings showed that the flagellated BP, but not the non-flagellated
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FIGURE 2 | BM and BP-induced time-dependent secretion of cytokines
from ATII cells and MDM. ATII cells and MDM were infected with BM or
BP (MOI 100:1) for 6 or 20h. Supernatant was collected and analyzed for
cytokine secretion. Un-stimulated cells served as baseline controls. BP
stimulated higher levels of IL-6 (A) and TNF-α (B) from MDM as well as IL-6
(D) and IL-8 (E) from ATII cells at 6 and 20 h post-infection compared to BM.
However, BM-induced significantly higher IL-10 secretion from MDM
compared to BP at 6 h post-infection (C). Additionally, IL-10 was significantly
secreted from BM-ATII cells compared to BP at both 6 and 20h post-infection
(F). Data is representative of two experiments containing duplicate
conditions/experiment and is represented as mean ± SEM. ∗denotes
significance of p < 0.05.
BM, readily adhered to ATII cells in the first 4 h post-infection.
BP’s motile and adhesion characteristics provided by flagella is
likely allowing a more intimate interaction with host cells, facili-
tating the phagocytosis of the bacteria, while non-flagellated BM
had minimal cellular adhesion in the early stages of infection.
BP flagellum was shown to be necessary to penetrate the mucous
lining the respiratory tract in order to gain access to host cells
in intranasal and intraperitoneal infection mice models (Chua
et al., 2003). Other studies have shown that an aflagellated BP
mutant was internalized significantly less by macrophages and
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FIGURE 3 | Phagocytosis and intracellular replication of BM and BP.
MDM and ATII cells were infected with BM or BP (MOI of 100:1). As
determined by CFUs, phagocytosis (accessed at 1 h) and intracellular
replication (accessed at 3 h post-infection) of BP by MDM was significantly
higher compared to BM (A). Alternatively, neither BM nor BP invaded or
replicated to high numbers in ATII cells (B). Data is representative of two
experiments containing duplicate conditions/experiment and is represented
as mean ± SEM. ∗denotes significance of p < 0.05 and ∗∗p < 0.01.
ATII cells as compared to wild type BP (Chuaygud et al., 2008).
Likewise, flagellin negative variants have been observed to be less
endocytosed than wild type flagellated BP, which signifies the
involvement of the BP flagellum in cellular invasion (Inglis et al.,
2003).
While the intact flagella structure contributes to the adherence
and invasion of a pathogen to host cells, it is the primary protein
component of the flagellum structure, known as flagellin, that
is now recognized as a major virulence factor of Gram-negative
organisms (Eaves-Pyles et al., 2001a,b, 2011; Chua et al., 2003;
Ramos et al., 2004; Chuaygud et al., 2008). The release of flag-
ellin monomers into the surrounding environment occurs when
the flagella are shed from the bacteria and the structure disas-
sembles due to environmental and chemical factors or deliberate
ejection from the bacteria (Ramos et al., 2004). Only after flagellin
monomers are free from the flagella filament do they bind to
and stimulate signaling pathways via their receptor, TLR5 (Smith
et al., 2003), resulting in the secretion of inflammatory cytokines
(Eaves-Pyles et al., 2001a,b, 2011). As such, we detected flagellin
in the supernatant of BP, but not BM, of infected cultures, lead-
ing to NF-κb activation via TLR5 stimulation. Additionally, BM,
as well as BP, stimulated TLR4 as both pathogens possess LPS
as a major outer membrane component. Our findings correlate
with other studies demonstrating the ability of BP to stimulate
TLR4 and TLR5 (Hii et al., 2008; West et al., 2008; Wiersinga
et al., 2008) and BM’s stimulation of TLR4 only (Brett et al.,
2007). Thus it is reasonable to conclude that as multiple TLRs are
subject to stimulation by BP, but not BM, this likely contributed
to the vigorous innate immune responses (e.g., cytokine secre-
tion) induced by macrophages and ATII cells in the early stages of
infection. Sim et al. (2009) showed that primary murine epithe-
lial lung cells both in vitro and in vivo secrete significant levels
of pro-inflammatory cytokines in response to BP. Our findings,
as well as others (Stevens and Galyov, 2004; Sim et al., 2009),
resemble the clinical situation of acute melioidosis in that this dis-
ease can lead to induction of pro-inflammatory cytokines with
high levels of cytokine secretion, leading to poorer prognosis
for infected patients (Simpson et al., 2000; Cheng et al., 2007;
Wiersinga et al., 2007). Alternatively, and very interestingly, BM
stimulated minimal cytokine secretion from macrophages and
ATII cells in the initial infection stage but stimulated the secre-
tion of pro-inflammatory suppressor, IL-10. However, cytokine
secretion from ATII cells and macrophages increased by 20 h
post-BM infection. A study by Brett et al. (2008) found that
BM was a weak inducer of cytokines, including IL-10, from a
macrophage cell line. Although both studies demonstrate a lack of
cytokine secretion by BM-infected macrophages, the differences
(i.e., IL-10 secretion) between these findings may be explained by
the fact that our studies used primary human monocytes-derived
macrophages in suspension while Brett et al. (Cheng et al., 2007)
tested monolayers of a murine macrophage-like cell line infected
with BM. As a result of our findings, we may hypothesize that the
lack of inflammatory cytokine secretion but increased secretion
of IL-10 by macrophages and ATII cells is a mechanism evolved
by BM to avoid detection by the host. This evasion by BM would
allow the pathogen time to adapt to the intracellular environment
and replicate before the host detects it and is able to mount an
effective, timely immune response.
Because alveolar macrophages are at the forefront of the host’s
immune defenses, it was not surprising thatmacrophages secreted
higher levels of cytokines overall in the response to BM and BP
compared to ATII cells. Additionally, although BP readily adhered
to ATII cells, there was minimal invasion of and replication in
ATII cells by both pathogens. Other studies have shown that
BP adhere, invade, and replicate to adequate numbers in trans-
formed ATII cell lines (Whitlock et al., 2009; Balder et al., 2010).
However, our studies herein are the first to examine Burkholderia
pathogenesis using primary human alveolar type II cells in a
physiological relevant ex vivomodel. While ATII cells are not pro-
fessional immune cells, they contribute significantly to the pul-
monary immune defenses against inhaled invaders via cytokine
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FIGURE 4 | BM and BP stimulation of various Toll-Like Receptors. To
determine if BM and/or BP stimulated various TLRs, HEK293 cells
expressing TLRs 4 and 5 and transfected with the firefly luciferase
plasmid pNiFty2-Luc were stimulated with BM or BP at an MOI of 100:1.
Un-stimulated cells served as negative controls. The TLR agonist served
as positive controls. The cells were incubated with live bacteria for 6 h.
The medium was then aspirated and replaced with fresh DMEM
without antibiotics and incubated overnight at 37◦C and 5% CO2. The
TLR agonists remained with the cells for an overnight incubation. The
following day, samples were analyzed to determine luciferase activity.
Data is expressed as relative luciferase activity. Both BM and BP (B)
stimulated TLR4 as effectively as the LPS agonist (A). However, the
flagellin from BP stimulated TLR5 (B) as we detected flagellin in the
medium of B-infected cells but not BM (C). Three experiments were
performed in using triplicate samples and data is represented as mean ±
SEM and ∗denotes significant differences of p < 0.01.
secretion and surfactant A and D (Crapo et al., 2000; Wright,
2005; Lhert et al., 2007; Chroneos et al., 2010). Our results suggest
that ATII cells are an important cytokine secreting cells resulting
from interactions with BM and BP, however, they are not a reser-
voir of invasion and intracellular replication for these pathogens,
which may open new avenues of the host innate immune response
for therapeutic treatment of melioidosis and glanders.
In conclusion, we have shown various distinct differences
between BM and BP pathogenesis regarding their interaction
with primary human ATII cells and macrophages. BM and BP
are similar in various aspects of their pathogenesis they produce
different disease outcomes. Our study demonstrates that each
of these pathogens has several unique strain specific character-
istics is revealed in their interactions with host cells to induce
varied host immune responses. By delineating host immune
responses to BM and BP we can better understand the pathogene-
sis of these pathogens and develop new directions for therapeutic
intervention and vaccines.
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